Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Veru Announces Presentation of Phase 3 Study of Sabizabulin for the Treatment of Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome at the 11th International Conference on Emerging Infectious Diseases (ICEID) on August 7-10, 2022
      Biotech

      Veru Announces Presentation of Phase 3 Study of Sabizabulin for the Treatment of Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome at the 11th International Conference on Emerging Infectious Diseases (ICEID) on August 7-10, 2022

      August 9, 2022
      ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call
      Biotech

      ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call

      August 9, 2022
      Heron Therapeutics Announces $76.5 Million Private Placement Financing
      Biotech

      Heron Therapeutics Announces $76.5 Million Private Placement Financing

      August 9, 2022
      Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Executive Officer
      Biotech

      Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Executive Officer

      August 9, 2022
      FibroGen Reports Second Quarter 2022 Financial Results
      Biotech

      FibroGen Reports Second Quarter 2022 Financial Results

      August 9, 2022
      Chinook Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
      Biotech

      Chinook Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results

      August 9, 2022
      Celldex Reports Second Quarter 2022 Financial Results and Provides Corporate Update
      Biotech

      Celldex Reports Second Quarter 2022 Financial Results and Provides Corporate Update

      August 9, 2022
      Vaxcyte Reports Second Quarter 2022 Financial Results and Provides Business Update
      Biotech

      Vaxcyte Reports Second Quarter 2022 Financial Results and Provides Business Update

      August 9, 2022
      Prothena Reports Second Quarter 2022 Financial Results and Business Highlights
      Biotech

      Prothena Reports Second Quarter 2022 Financial Results and Business Highlights

      August 9, 2022
      Krystal Biotech Announces Second Quarter 2022 Financial Results and Reports Updates on Operational Progress
      Biotech

      Krystal Biotech Announces Second Quarter 2022 Financial Results and Reports Updates on Operational Progress

      August 9, 2022
      « 1 … 127 128 129 130 131 … 142 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026